Secondary Myelodysplastic Syndrome

hematologic malignancy

Identifier: CI-CAN-00001492
Entity page: /cancer/secondary-myelodysplastic-syndrome ↗
Edges: 62

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Secondary Myelodysplastic Syndrome investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 29show all (up to 200)
→ investigated in trials for	Fludarabinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants	—	—	Secondary Myelodysplastic Syndrome	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidine

Secondary Myelodysplastic Syndrome studied in …STUDIED_INderived10 of 33show all (up to 200)
→ studied in	NCT03630991Phase 1 · recruiting Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active)	—	—	Secondary Myelodysplastic Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT02890329Phase 1 · active not recruiting Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active)	—	—	Secondary Myelodysplastic Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT01885689Phase 2 · active not recruiting Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active)	—	—	Secondary Myelodysplastic Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ALIAS · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT04550442Phase 1/Phase 2 · terminated Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia · condition mapped ALIAS · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT05146739Phase 1 · active not recruiting Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane · condition mapped ONTOLOGY_EXACT · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT05292664Phase 1 · recruiting Venetoclax Basket Trial for High Risk Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →
→ studied in	NCT05316701Phase 3 · active not recruiting Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ALIAS · 33 trials mapped (9 active)	—	—	Myelodysplastic Syndrome Post Cytotoxic Therapy	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains